partnership deals. ���We are working together to evaluate areas of potential collaboration,��� Dong Ruiping, Merck���s head of emerging markets research and development, said in an e-mailed statement about the BeiGene investment. He declined to disclose...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to China���s Cancer Deaths Spur Merck Investment in Beijing Biotech
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account